![Douglas Manion](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Manion
Vorsitzender bei
LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC.
Vermögen: 10 654 $ am 30.06.2026
Profil
Douglas J.
Manion is currently Chairman at Lakewood-Amedex Biotherapeutics, Inc. and Chairman at Lakewood-Amedex, Inc., both positions starting in 2025.
Former roles include Chief Executive Officer & Director at Flare Therapeutics, Inc. from 2024 to 2026; President, Chief Executive Officer & Director at Aclaris Therapeutics, Inc. from 2023 to 2024; Executive Vice President-Research & Development at Arena Pharmaceuticals, Inc. from 2021 to 2022; Chairman & Chief Executive Officer at Kleo Pharmaceuticals, Inc. from 2020 to 2021; Senior Vice President & Head-Specialty Development at Bristol Myers Squibb Co. from 2014 to 2016; Vice President-Clinical Development & Medical Affairs at GSK Plc from 2001 to 2005; and Non-Executive Director at Celleron Therapeutics Ltd. Education includes undergraduate and doctorate degrees from the University of Ottawa.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.04.2026 | 3’393 ( 0.19% ) | 10 654 $ | 30.06.2026 |
Aktive Positionen von Douglas Manion
| Unternehmen | Position | Beginn |
|---|---|---|
| LAKEWOOD-AMEDEX BIOTHERAPEUTICS, INC. | Vorsitzender | 12.02.2025 |
Lakewood-Amedex, Inc.
 Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-infective pharmaceuticals for the treatment of serious infectious diseases | Vorsitzender | 13.02.2025 |
Ehemalige bekannte Positionen von Douglas Manion
| Unternehmen | Position | Ende |
|---|---|---|
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Vorstandsvorsitzender | 30.06.2026 |
| ACLARIS THERAPEUTICS, INC. | Vorstandsvorsitzender | 16.01.2024 |
| ARENA PHARMACEUTICALS | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
Kleo Pharmaceuticals, Inc.
 Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Vorstandsvorsitzender | 31.01.2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 19.02.2013 |
Ausbildung von Douglas Manion
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Ottawa
 University of Ottawa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amedex Therapeutics, Inc.
 Amedex Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel antimicrobial therapeutics | Health Technology |
Celleron Therapeutics Ltd.
 Celleron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which advancing a pipeline of precision medicine drugs for cancer indications | Health Technology |
Lakewood-Amedex, Inc.
Lakewood-Amedex, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-infective pharmaceuticals for the treatment of serious infectious diseases | Health Technology |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Commercial Services |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
